Spectral Precise Image study for brain tumors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects data from patients with confirmed brain tumors who had contrast-enhanced Spectral CT 7500 scans. It aims to describe image quality and how confident clinicians feel about diagnoses using the spectral deep learning reconstruction. Data will be analyzed to characterize the performance of Spectral Precise Image in this patient population. No experimental interventions are performed; the study observes routine imaging data and clinical information. The study is conducted at Union Hospital in Wuhan, in collaboration with Tongji Medical College and Huazhong University of Science and Technology.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients with clinical and radiology (MRI/CT) diagnosed brain tumors.
2. Patients who underwent contrast enhanced scans using the Spectral CT 7500.
3. Study participants with age ≥ 18 years old.
4. Study participants that have signed Informed Consent Form (ICF)

Exclusion Criteria:

1. The clinical data or radiological information is considered incomplete after evaluation by the investigator.
2. Study participant that was enrolled in this study in the past
3. Data from study participants deemed unsuitable for enrollment based on the investigator's evaluation

Where it's running

• Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
  Wuhan, Hubei, China Recruiting

Study contacts

• Principal investigator: Jing Wang — 1277 Jiefang Avenue, Wuhan, Hubei Province, P. R. China
• Study coordinator: Jing Wang
• Email: xhwangjing@hust.edu.cn
• Phone: +8613986085216

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Smart Holistic Health Care Platform for families of children with cancer

  Aims to see if two smart platforms for parents and children with leukemia or brain tumors in Taiwan can improve quality of life and overall well-being during treatment.

  Recruiting National Defense Medical Center, Taiwan · Taipei · NCT07805096

• rTMS to improve movement after brain tumor surgery

  This pilot will try whether short courses of daily TMS can help adults with new or ongoing movement weakness after brain tumor surgery recover strength and function.

  Recruiting Columbia University · New York, New York · NCT07530536

• Early post-operative brain PET-MRI in glioblastoma surgery

  This study tests whether doing PET-MRI soon after glioblastoma surgery is safe and feasible and whether imaging with 18F-DOPA can better detect residual tumor than standard MRI.

  Recruiting Beta Emitting Accurate Monitored Systems · Créteil · NCT07274397

• Vision-language AI to diagnose brain diseases from imaging and clinical data

  This project will test a new AI that reads scans, pathology, genomics, and clinical records to help diagnose a wide range of brain diseases for patients with tumors, vascular problems, or neurodegeneration.

  Recruiting Xiangya Hospital of Central South University · Changsha, Hunan · NCT07126821

• Improving care pathways for patients with rare brain tumors using AI

  This study is testing whether using AI to improve treatment plans can help people with rare brain tumors have better care and quality of life through a home rehabilitation program.

  Recruiting Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Milan, PA and 1 other locations · NCT06878469

• Comparing IV methadone versus IV remifentanil for pain and recovery after craniotomy

  This trial will test whether a single dose of IV methadone given during surgery provides better pain control and recovery than IV remifentanil for adults having supratentorial craniotomy.

  Recruiting Early Phase 1 University of Virginia · Charlottesville, Virginia · NCT06810336

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.